Literature DB >> 31325806

Assessing depression improvement with the remission evaluation and mood inventory tool (REMIT).

Michael A Bushey1, Kurt Kroenke2, Fitsum Baye3, Spencer Lourens3.   

Abstract

OBJECTIVE: The Remission Evaluation and Mood Inventory Tool (REMIT) was developed as a brief complementary measure to provide a more robust assessment of depression improvement than tracking DSM-V symptom improvement alone. This study provides further validation of the REMIT tool and examines its utility in predicting depression improvement.
METHODS: The sample comprised 294 primary care patients enrolled in a telecare trial of pain plus depression and/or anxiety. Assessments collected included: REMIT, PHQ-9 and measures assessing anxiety, pain, sleep, fatigue, somatization, health-related quality of life and disability. Data was analyzed to assess the REMIT's validity, its minimally important difference (MID), and its utility in predicting 6-month depression improvement.
RESULTS: Convergent and construct validity of REMIT was supported by moderate correlations with mental health measures and weaker correlation with physical health measures. MID of approximately 2 points for REMIT was estimated by two metrics: 0.5 standard deviation and 1 standard error of measurement. Both baseline and 3-month change in REMIT scores predicted depression improvement at 6 months. Indeed, REMIT was as good or better predictor than the PHQ-9.
CONCLUSION: The REMIT measure is a brief 5-item tool that augments core DSM-V symptom-oriented metrics in assessing and predicting recovery from major depression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Measurement-based care; Recovery; Remission; Remission evaluation and mood inventory tool (REMIT)

Mesh:

Year:  2019        PMID: 31325806     DOI: 10.1016/j.genhosppsych.2019.07.007

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  2 in total

1.  The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients.

Authors:  Robert M Bossarte; Ronald C Kessler; Andrew A Nierenberg; Ambarish Chattopadhyay; Pim Cuijpers; Angel Enrique; Phyllis M Foxworth; Sarah M Gildea; Bea Herbeck Belnap; Marc W Haut; Kari B Law; William D Lewis; Howard Liu; Alexander R Luedtke; Wilfred R Pigeon; Larry A Rhodes; Derek Richards; Bruce L Rollman; Nancy A Sampson; Cara M Stokes; John Torous; Tyler D Webb; Jose R Zubizarreta
Journal:  Trials       Date:  2022-06-20       Impact factor: 2.728

2.  Responsiveness of PROMIS and Patient Health Questionnaire (PHQ) Depression Scales in three clinical trials.

Authors:  Kurt Kroenke; Timothy E Stump; Chen X Chen; Jacob Kean; Teresa M Damush; Matthew J Bair; Erin E Krebs; Patrick O Monahan
Journal:  Health Qual Life Outcomes       Date:  2021-02-04       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.